Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows From Operating Activities
Net loss attributable to ChromaDex Corporation	$ (1,902)	$ (7,740)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of leasehold improvements and equipment	228	201
Amortization of intangibles	41	49
Amortization of right of use assets	171	299
Share-based compensation expense	1,273	1,888
Provision for doubtful trade receivables	316	10
Non-cash financing costs	21	18
Changes in operating assets and liabilities:
Trade receivables	(1,084)	(1,094)
Inventories	2,769	(1,706)
Implementation costs for cloud computing arrangement	(27)	(114)
Prepaid expenses and other assets	616	46
Accounts payable	(728)	(643)
Accrued expenses	1,273	1,645
Customer deposits and other	(6)	(18)
Operating lease liabilities	(169)	(39)
Net cash provided by (used in) operating activities	2,792	(7,198)
Cash Flows From Investing Activities
Purchases of leasehold improvements and equipment	(91)	(25)
Net cash used in investing activities	(91)	(25)
Cash Flows From Financing Activities
Principal payments on finance leases	(1)	(3)
Net cash used in financing activities	(1)	(3)
Net increase (decrease) in cash and cash equivalents	2,700	(7,226)
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	20,441	28,219
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	23,141	20,993
Supplemental Disclosures of Cash Flow Information
Cash payments for principal on operating lease liabilities	180	58
Supplemental Schedule of Noncash Operating Activity
Stockholders' equity attributable to parent	$ (28,017)	$ (25,877)